Citação norma APA

Mollica, V., Brocchi, S., Dall’Olio, F. G., Marcolin, L., Paccapelo, A., Santoni, M., . . . Ardizzoni, A. (2021). Tumor Growth Rate Decline despite Progressive Disease May Predict Improved Nivolumab Treatment Outcome in mRCC: When RECIST Is Not Enough. Cancers (Basel).

Citação norma Chicago

Mollica, Veronica, et al. "Tumor Growth Rate Decline Despite Progressive Disease May Predict Improved Nivolumab Treatment Outcome in MRCC: When RECIST Is Not Enough." Cancers (Basel) 2021.

Citação norma MLA

Mollica, Veronica, et al. "Tumor Growth Rate Decline Despite Progressive Disease May Predict Improved Nivolumab Treatment Outcome in MRCC: When RECIST Is Not Enough." Cancers (Basel) 2021.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.